Nature’s First Nutrition Meets Nature’s First Fountain of Youth in One Formula

Aristaeos_Tag

Each mountain olive tree carries its own yellow plaque bearing the name Aristaeos Cooperativa Mediterranea together with its exact geographical coordinates.
Each mountain olive tree carries its own yellow plaque bearing the name Aristaeos Cooperativa Mediterranea together with its exact geographical coordinates.

Aristaeos_Bottle

ARISTAEOS Colostrum + Hydroxytyrosol - bringing together two of nature’s most extraordinary biological creations for the first time.
ARISTAEOS Colostrum + Hydroxytyrosol – bringing together two of nature’s most extraordinary biological creations for the first time.

SANTA MONICA, CA, Sept. 14, 2026 (GLOBE NEWSWIRE) — Oliveda International, Inc. (OTCID: OLVI) today announced the introduction of ARISTAEOS—the world’s first combination of colostrum and hydroxytyrosol – by its OLIVE TREE PEOPLE subsidiary. ARISTAEOS brings together two of nature’s most extraordinary biological creations for the first time in one formula.

More than 23 years ago, when Olive Tree People Founder Thomas Lommel began his journey with the olive tree, he immersed himself in its history, mythology and ancient knowledge.

There he discovered Aristaeos—the Greek god and guardian of olive cultivation, credited with teaching humanity how to cultivate wild olive trees and produce olive oil.

Inspired by this story, Lommel conceived Aristaeos Cooperativa Mediterranea, a Mediterranean cooperative centered around the olive tree and the people who cultivate it.

Every one of the company’s mountain olive trees is eco-certified. Each tree carries its own yellow plaque bearing the name Aristaeos Cooperativa Mediterranea together with its exact geographical coordinates.

No tree is anonymous.
Every tree has its own place.
Every tree has its own identity.

Now the name returns.

With ARISTAEOS Colostrum + Hydroxytyrosol, Olive Tree People brings together two of nature’s most extraordinary biological creations for the first time.

Colostrum is nature’s first nutrition – a naturally complex bioactive matrix created at the beginning of life.

Hydroxytyrosol is part of the protective intelligence of the olive tree – nature’s living fountain of youth. A tree capable of surviving, regenerating and remaining productive for thousands of years, with individual olive trees estimated to be as old as 4,000 years.

One is created at the beginning of life.
The other comes from nature’s ancient fountain of youth.

For the first time, they meet in one formula.

Each serving of ARISTAEOS combines 2 grams of premium grass-fed bovine colostrum concentrate with 5 milligrams of olive leaf extract, naturally providing 0.3 milligrams of hydroxytyrosol.

The olive leaf extract is derived from leaves grown on Olive Tree People’s own eco-certified mountain olive trees in Andalusia, Spain.

Mr. Lommel commented, “Colostrum represents the beginning of life. The olive tree represents nature’s ancient fountain of youth. With ARISTAEOS, we are bringing these two worlds together for the first time – Nature’s first nutrition united with hydroxytyrosol from our own olive trees. This is not another colostrum. It is the beginning of an entirely new category.”

ARISTAEOS is made in the United States and contains 60 daily servings.

ARISTAEOS Colostrum + Hydroxytyrosol
NATURE’S FIRST NUTRITION MEETS NATURE’S LIVING FOUNTAIN OF YOUTH.

About Olive Tree People
Olive Tree People is a pioneer and leading force in waterless beauty. Instead of using the conventional water phase found in most skincare products, the company replaces water with its proprietary olive leaf cell elixir and combines it with powerful olive-tree ingredients, including Hydroxytyrosol.

Founded by olive tree farmer Thomas Lommel, Olive Tree People develops skincare, beauty and holistic experiences based on more than 20 years of work with mountain olive trees and the principles of Olive Tree Therapy.

About Oliveda International, Inc. 
Oliveda International, Inc. and its subsidiary, Olive Tree People Inc., as well as the European companies, Olive Tree People Europe AG, Oliveda Deutschland GmbH, and Olive Tree Farmers SL, were founded by the German real estate investor Thomas Lommel. The companies possess over 20 years of experience in management and organic certification growing mountain olive trees; in the extraction of first-class, internationally award-winning extra virgin olive oils; the extraction of hydroxytyrosol; and the production and distribution of cosmetic and holistic waterless products related to the olive tree.  Lommel is the inventor of the “Olive Tree Therapy 10 Years in 14 Days” as well as the inventor of olive matcha, which is based on the ground olive leaf. Also unique is the coffee replacement developed by Lommel, which is based on the olive leaf and hydroxytyrosol.  In addition, Lommel is successfully active in the rapidly growing mindfulness industry with the olive tree sound bath meditation he developed and the frequencies of his olive trees, which he makes available worldwide.

In addition to the registered beauty brands, Oliveda and LA Dope, as well as the brands Olive Rose, OLIVE re:connected to Nature, The Intuition of Nature, Olive Mush, Baby & Mom, and Is That Matty?, Lommel is the region’s largest conservationist and protector of over 30,000 one-hundred-year-old mountain olive trees. With his Thomas Lommel Foundation, he brings the water that he does not use into his waterless beauty products to the people of Africa by building water wells on site.

The company’s direct-to-consumer network includes tens of thousands of Waterless Beauty Consultants in North America and Europe. In addition to online sales and a Europe-wide branch network of thousands of retail stores, Oliveda Deutschland GmbH operates its own flagship stores in Berlin and Düsseldorf.

The brand’s treatment concepts are unique worldwide, and their effectiveness has been confirmed by conventional medicine.  Read our book The Olive Tree Therapy 10 Years in 14 Days. Waterless beauty has been called “The Next Big Thing” in articles in U.S. Vogue, Harper’s Bazaar, InStyle, Elle, Madame, Forbes, and many other industry publications, as well as by Mintel, a world-leading futurology institute.  Gigi Hadid and many other celebrities are already Oliveda fans and support its success.  Further information on Oliveda International, Inc. and its subsidiaries and associate companies and brands can be found at www.olivetreepeople.com

Forward-Looking Statements
This press release may contain statements, estimates or projections that constitute “forward-looking statements” pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company’s historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made.  The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law.

Attachments

CONTACT: OLVI Investor Relations
619-202-7456
olvi@advanceprgroup.com

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES

The base shelf prospectus is accessible, and the shelf prospectus supplement will be accessible within two business days through SEDAR+

TORONTO, Sept. 14, 2026 (GLOBE NEWSWIRE) — Primaris Real Estate Investment Trust (“Primaris” or the “Trust”) (TSX:PMZ.UN) announced today that it has entered into an agreement with a syndicate of underwriters bookrun by TD Securities Inc., Desjardins Capital Markets and RBC Capital Markets (the “Underwriters”), pursuant to which the Underwriters will purchase, on a bought-deal basis, an aggregate of 9,910,000 units of Primaris (“REIT Units”) at a price of $20.20 per REIT Unit (the “Offering”) for gross proceeds of approximately $200 million. The Offering is expected to close on or about September 22, 2026, and is subject to customary closing conditions, including the approval of the Toronto Stock Exchange.

Primaris has granted the Underwriters an over-allotment option to purchase up to an additional 1,486,500 REIT Units from treasury on the same terms and conditions, exercisable at any time, in whole or in part, for a period of 30 days following the closing of the Offering. If the over-allotment option is exercised in full, the total gross proceeds of the Offering to Primaris will be approximately $230 million.

Primaris intends to use the net proceeds from the Offering to fund the Trust’s future acquisitions and for general trust purposes. The Trust is in various stages of negotiations on potential acquisitions with an aggregate potential purchase price of over $1 billion. 

“Primaris continues to benefit from a strong balance sheet, growing cash flow and a differentiated portfolio of market-leading enclosed shopping centres. This offering further enhances our financial flexibility and liquidity, positioning us to capitalize on attractive acquisition opportunities while maintaining our disciplined approach to capital allocation and leverage management,” said Alex Avery, Chief Executive Officer.

The REIT Units will be offered in all provinces and territories of Canada pursuant to Primaris’ base shelf prospectus, dated September 8, 2026, as supplemented by a prospectus supplement to be filed with the Canadian securities regulators in all of the provinces and territories of Canada. Access to the shelf prospectus supplement, the corresponding base shelf prospectus and any amendment to the documents is provided in accordance with securities legislation relating to procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment to the documents. The base shelf prospectus is accessible, and the shelf prospectus supplement will be accessible within two business days, through SEDAR+ at www.sedarplus.ca.

An electronic or paper copy of the shelf prospectus supplement, the corresponding base shelf prospectus and any amendment to the documents may be obtained, without charge, from: TD Securities Inc. at 1625 Tech Avenue, Mississauga, Ontario, L4W 5P5, Attention: Symcor, NPM, or by telephone at (289) 360-2009 or by email at sdcconfirms@td.com; or Desjardins Capital Markets at 25 York St., 10th Floor, Toronto, Ontario M5J 2V5, Attention: Equity Capital Markets or by email at ecm@desjardins.com; or RBC Dominion Securities Inc., 180 Wellington Street West, 8th Floor, Toronto, Ontario M5J 0C2, Attention: Distribution Centre, by e-mail at Distribution.RBCDS@rbccm.com; by providing the contact with an email address or address, as applicable. The base shelf prospectus and prospectus supplement will contain important detailed information about the Trust and the Offering. Prospective investors should read the shelf prospectus and prospectus supplement (when filed) and the other documents the Trust has filed on SEDAR+ before making an investment decision.

The REIT Units have not been, and will not be, registered under the United States Securities Act of 1933, as amended, (the “U.S. Securities Act”) or any state securities law and may not be offered or sold in the United States and, accordingly, may not be offered, sold or delivered, directly or indirectly, in the United States or to, or for the account or benefit of, U.S. Persons except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the REIT Units in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Primaris Real Estate Investment Trust

Primaris is Canada’s only enclosed shopping centre focused REIT, with ownership interests in leading enclosed shopping centres located in growing Canadian markets. The current portfolio totals 14.6 million square feet, valued at approximately $5.2 billion at Primaris’ share. Economies of scale are achieved through its fully internal, vertically integrated, full-service national management platform. Primaris is very well-capitalized and is exceptionally well positioned to take advantage of market opportunities at an extraordinary moment in the evolution of the Canadian retail property landscape.

Forward-Looking Statements

Certain statements included in this news release constitute ‘‘forward-looking information’’ or “forward-looking statements” within the meaning of applicable securities laws. The words “will”, “expects”, “plans”, “estimates”, “intends” and similar expressions are often intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Specific forward-looking statements made or implied in this news release include but are not limited to statements regarding: the terms of the REIT Units, the date of closing of the Offering, the use of proceeds from the Offering and the issuance of REIT Units, if any, pursuant to the over-allotment option, the enhancement of financial flexibility and liquidity as a result of the Offering and acquisition opportunities. Forward-looking statements are provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements are not guarantees of future performance and are based on estimates and assumptions that are inherently subject to risks and uncertainties. Primaris cautions that although it is believed that the assumptions are reasonable in the circumstances, actual results, performance or achievements of Primaris may differ materially from the expectations set out in the forward-looking statements. Material risk factors and assumptions include those set out in the Trust’s management’s discussion and analysis for the year ended December 31, 2025 and 2024, which is available on SEDAR+, and in Primaris’ other materials filed with the Canadian securities regulatory authorities from time to time.

For more information:

TSX: PMZ.UN www.primarisreit.com www.sedarplus.ca
Alex Avery
Chief Executive Officer
416-642-7837
aavery@primarisreit.com

Rags Davloor
Chief Financial Officer
416-645-3716
rdavloor@primarisreit.com
Julian Schonfeldt
Chief Investment Officer
647-212-6519
jschonfeldt@primarisreit.com
Claire Mahaney
VP, Investor Relations & ESG
647-949-3093
cmahaney@primarisreit.com
Timothy Pire
Chair of the Board
chair@primarisreit.com
     

The prospectus supplement, the corresponding base shelf prospectus and any amendment thereto in connection with the Bought Deal Financing (as defined below) will be accessible through SEDAR+ within two business days

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Sept. 14, 2026 (GLOBE NEWSWIRE) — Generation Mining Limited (TSX: GENM) (OTCQB: GENMF) (“Generation” or the “Company”) is pleased to announce that it has secured $340 million representing the final funding and financing component (“Final Funding”) required to complete the fully financed construction package for its 100%-owned Marathon Copper-Palladium Project (the “Marathon Project”), located near Marathon, Northwestern Ontario, Canada, including anchor investments of approximately $140 million from Canada Growth Fund (“CGF”) and $50 million from Canada Infrastructure Bank (“CIB”).

With the Final Funding now in place, together with the previously announced senior secured debt, subordinated debt, undrawn portion of the metal stream, and estimated equipment leasing (“Previously Announced Financings”), Generation has arranged the financing required for construction of the Marathon Project.

Highlights of the Final Funding are as follows:

  • Bought deal financing of $200 million (the “Bought Deal Financing”) of which an aggregate of approximately $100 million was committed to by CGF, Wheaton Precious Metals, and Glencore Canada Corporation (“Glencore Canada”).
  • Private placement (the “Private Placement”) of $40 million by CGF.
  • Subordinated Unsecured Convertible Note (the “Note Financing”) of $100 million pursuant to the following allocations: $50 million by CGF and $50 million by CIB.

In addition to the Final Funding, the Company and Glencore AG (collectively with Glencore Canada, “Glencore”) have agreed to terms with respect to a copper and metal supply contract (the “Offtake Agreement”), pursuant to which Glencore AG agreed to purchase polymetallic copper concentrate containing copper, palladium, platinum, gold and silver produced at the Marathon Project. The Concentrate will support domestic value-added processing at Glencore Canada’s Horne smelter in Rouyn-Noranda, Québec (Canada’s only copper smelter) as well as Glencore Canada’s CCR refinery and further domestic value-added processing.

Taken together, the Final Funding and the Previously Announced Financings (see press releases dated June 17, 2026, June 22, 2026, and March 31, 2022) represent a fully financed construction package of approximately $1.3 billion (“Fully Financed Construction Package”). The Board is expected to convene and make a final investment decision following the completion of all financings comprising the Final Funding.

The Bought Deal Financing, Private Placement, Note Financing and Previously Announced Financings remain subject, where applicable, to shareholder, stock exchange and other required regulatory approvals, execution of definitive documentation, intercreditor agreements and satisfaction of customary conditions precedent.

The Fully Financed Construction Package incorporates a $185 million cost overrun facility for the benefit of the senior lenders of which $95 million will be funded under the Final Funding and $90 million of which will be funded under the previously-announced CIB subordinated debt facility (see press release dated June 22, 2026). This is in addition to the $119 million contingency portion of the capital costs to build the mine. The Fully Financed Construction Package also includes surety bonds for closure and fisheries offset commitments as well as letters of credit totaling $78 million.  

Jamie Levy, President and Chief Executive Officer, stated, “Today is a landmark day for Generation Mining. With the Final Funding now secured, we have completed a fully financed construction package for the Marathon Project. This important milestone was made possible by the complementary tools put in place by the Government of Canada to help complete the project’s financing stack, with CGF providing equity financing and CIB providing debt financing. With financing now complete, we are thrilled to begin early works construction in Q4 2026 and move the Marathon Project toward production as Canada’s next major producer of copper and palladium.”

Brian Jennings, Chief Financial Officer stated, “To assemble project capital totaling approximately $1.3 billion for a company of our size is a significant accomplishment. This could not have been done without the support of CGF, CIB, Wheaton Precious Metals, Glencore, senior lenders, our equity partners and advisors. This project will be a generational asset for our shareholders and for Canada’s critical minerals sector, and I want to sincerely thank everyone involved.”

“CGF was established to unlock strategic projects across Canada by deploying capital through specialized financial instruments that mobilize private investment into strategically important assets,” said Yannick Beaudoin, President and Chief Executive Officer of Canada Growth Fund Investment Management Inc. (“CGFIM”). “Building on its investment expertise, CGFIM has helped support the Marathon Project and is advancing a new Canadian source of copper and palladium, strengthening critical minerals supply chains and supporting long-term economic growth.”

Ehren Cory, Chief Executive Officer of the Canada Infrastructure Bank, shared, “The Marathon Project will help build a resilient, made-in-Canada supply chain for the critical minerals that power our clean economy. We are pleased to make our first investment in Ontario’s critical minerals sector and we look forward to seeing construction get underway.”

Details of the Final Funding and Offtake Agreement summarized above are as follows:

Bought Deal Financing

In connection with the Bought Deal Financing, the Company entered into an agreement with BMO Capital Markets as sole bookrunner on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 312,500,000 common shares of the Company (the “Common Shares”) at a price of $0.64 per Common Share for gross proceeds of $200 million. The Bought Deal Financing is expected to close on or about September 21, 2026 and is subject to the Company receiving all necessary regulatory approvals, including the approval of the Toronto Stock Exchange (“TSX”).

The Company intends to use the net proceeds from the Bought Deal Financing (and the Private Placement and Note Financing) to fund the development, construction and operation of the Marathon Project, and associated general and administrative and financing costs.

The Common Shares to be issued pursuant to the Bought Deal Financing will be offered: (i) in each of the provinces and territories of Canada, except Québec and Nunavut, by way of a prospectus supplement (the “Prospectus Supplement”) to the Company’s short form base shelf prospectus dated February 24, 2026 (the “Base Shelf Prospectus”), which Prospectus Supplement will be filed with the securities commissions within two business days; (ii) in the United States or to or for the account or benefit of “U.S. persons” as defined by Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), by way of private placement pursuant to the exemption from registration provided for under Section 4(a)(2) of the U.S. Securities Act and the applicable securities laws of any state of the United States; and (iii) in jurisdictions outside of Canada and the United States as are agreed to by the Company and the Underwriters on a private placement or equivalent basis.

Access to the Prospectus Supplement, the Base Shelf Prospectus and any amendment to such documents is provided in accordance with securities legislation relating to the procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment. The Base Shelf Prospectus is, and the Prospectus Supplement will be (within two business days from the date hereof), accessible on SEDAR+ at www.sedarplus.ca. An electronic or paper copy of the Prospectus Supplement, Base Shelf Prospectus, and any amendment to such documents may be obtained, without charge, by contacting BMO Nesbitt Burns Inc. by mail at Brampton Distribution Centre c/o The Data Group of Companies, 9195 Torbram Road, Brampton, ON, L6S 6H2, by telephone at 905-791-3151 Ext 4312, or by email at torbramwarehouse@datagroup.ca.

The securities being offered have not been, nor will they be, registered under the U.S. Securities Act, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Private Placement

CGF provided the Company with an equity commitment letter whereby it agreed to subscribe through a subsidiary, on a private placement basis, for Common Shares and Convertible Notes, subject to certain conditions. Pursuant to the Private Placement, the Company will issue an aggregate 62,500,000 Common Shares at a price of $0.64 per Common Share, for gross proceeds of $40 million. The closing of the subscription by CGF shall occur immediately following the issuance of the Common Shares pursuant to the Bought Deal Financing, and remains subject to the approval of the TSX.

As a condition to the completion of the equity investment by CGF, the Company and CGF have agreed to enter into an investor rights agreement providing CGF with certain board nomination and observer rights, registration rights, as well as pre-emptive and top-up rights in connection with future offerings and certain dilutive events, in each case subject to CGF maintaining specified ownership thresholds in the Company.

Convertible Note

The Convertible Notes were priced at a 40% conversion premium to the Bought Deal Financing and Private Placement pricing (the “Conversion Price”), carry an interest rate of 9% per annum payable semi-annually, and have a term ending on the earlier of (a) 11 years from issuance and (b) where the senior debt facility and CIB Subordinated Facility have been repaid or refinanced in full, the later of 7 years from issuance and 12 months following such repayment or refinancing.

The Convertible Notes have an optional conversion right in favour of the Company if at any time after the third anniversary of issuance of the Convertible Notes the last reported sale price of Generation for 20 or more trading days in a period of 30 consecutive trading days ending on the trading day prior to the date Generation provides notice of the early conversion exceeds 130% of the Conversion Price. Interest may be paid in cash or, subject to the distribution conditions of the Company’s project finance facilities, on a payment-in-kind (“PIK”) basis.

The Convertible Notes are unsecured, subordinated obligations of Generation and are convertible into Common Shares, subject to a 19.9% beneficial ownership limitation per noteholder.

Completion of the Note Financing is subject to specified shareholder approvals in accordance with applicable regulatory requirements, including the TSX. The Company anticipates convening a special shareholder meeting scheduled for Q4, 2026 in which such shareholder approvals will be sought.

Offtake Agreement

The terms of the Offtake Agreement provide that upon the date of first commercial production at the Marathon Project, and continuing for the life-of-mine, subject to a minimum contractual term of 14 years commencing September 1, 2028, Glencore AG will buy 100% of concentrate production in the first two calendar years following first commercial production and from year 13 of the contract onward. In the intervening years, Glencore AG is entitled to receive approximately 50% of annual mine production pursuant to an agreed annual scheduling mechanism that accommodates the Company’s other offtake commitments.

Advisors

BMO Capital Markets is acting as sole bookrunner on the Bought Deal, and Endeavour Financial is acting as project financing advisor to the Company. Cassels Brock & Blackwell LLP and A&O Shearman and are acting as legal advisors to the Company for the equity and project financing of the Marathon Project. Norton Rose Fulbright Canada LLP is acting as legal advisor to CGF, CGFIM and CIB. Miller Thomson LLP is acting as legal advisor for the Underwriters.

Qualified Person

The scientific and technical content of this news release has been reviewed and approved by Daniel Janusauskas, P.Eng., Technical Services Manager of Generation PGM, and a Qualified Person as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Generation Mining Limited

Generation Mining’s (TSX: GENM) focus is the development of the Marathon Project, a large undeveloped copper-palladium deposit in Northwestern Ontario. The Feasibility Study (the “Technical Report”) with an effective date of November 1, 2024, estimated a Net Present Value (using a 6% discount rate) of $1.07 billion, an Internal Rate of Return of 28%, and a 1.9-year payback based on the 3-yr trailing average metal prices at the effective date of the Technical Report. Over the anticipated 13-year mine life, the Marathon Project is expected to produce approximately: 2,161,000 ounces of palladium, 532 million lbs. of copper, 488,000 ounces of platinum, 160,000 ounces of gold and 3,051,000 ounces of silver in payable metals. These production estimates and economic projections are forward-looking statements subject to risks and uncertainties. For more information, please review the Technical Report filed under the Company’s profile at www.sedarplus.ca and available on the Company’s website at https://genmining.com/projects/feasibility-study/.

About Canada Growth Fund 

CGF is a $15 billion arm’s-length investment vehicle designed to attract private capital to build Canada’s clean economy. It uses investment instruments that absorb certain risks to catalyze private investment in low-carbon projects, technologies, businesses, and supply chains. Visit http://www.cgf-fcc.ca for more information.

For CGF’s Media relations, contact mediacgf@cgf-fcc.ca.

About Canada Growth Fund Investment Management

In Budget 2023, the Government of Canada appointed PSP Investments, through a wholly owned subsidiary, to act as the asset manager for CGF. CGFIM serves as the independent and exclusive asset manager for CGF.

About Canada Infrastructure Bank

The CIB is an impact investor developing the next generation of infrastructure Canadians need. The CIB brings business, investors, Indigenous communities and government together to help deliver outcomes like sustainable economic growth, energy security and competitiveness. The CIB has invested more than $19 billion towards 115 projects, 17 of which are now complete and supporting economic growth and jobs nationwide. www.cib-bic.ca.

For further information, please contact:

Jamie Levy
President and Chief Executive Officer
(416) 640-2934 (O)
(416) 567-2440 (M)
jlevy@genmining.com
info@genmining.com

Forward-Looking Information

This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as “forward-looking statements”). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company’s future performance. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved, including statements relating to the filing of the Prospectus Supplement, the proposed use of proceeds of the Bought Deal Financing, Private Placement and Note Financing, receipt of all regulatory and shareholder approvals related to the Bought Deal Financing, Private Placement and Note Financing, the completion of the Bought Deal Financing, Private Placement and Note Financing including the expected closing date of each, the timing of the commencement of construction and the anticipated advancement of the Company’s Marathon Project.

Although the Company believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information. These include

These include the timing of the Bought Deal Financing, Private Placement and Note Financing and regulatory and shareholder approvals, as applicable; the progress of development at the Marathon Project, including progress of project expenditures and contracting processes, the Company’s plans and expectations with respect to liquidity management, continued availability of capital and financing, the future prices of palladium, copper and other commodities, permitting timelines, exchange rates and currency fluctuations, increases in costs, requirements for additional capital, and the Company’s decisions with respect to capital allocation, inflation, global supply chain disruptions, global conflicts, the project schedule for the Marathon Project, key inputs, staffing and contractors, continued availability of capital and financing, uncertainties involved in interpreting geological data and the accuracy of mineral reserve and resource estimates, environmental compliance and changes in environmental legislation and regulation, the Company’s relationships with Indigenous communities, results from planned exploration and drilling activities, local access conditions for drilling, and general economic, market or business conditions, as well as those risk factors set out in the Company’s annual information form for the year ended December 31, 2025, and in the continuous disclosure documents filed by the Company on SEDAR+ at www.sedarplus.ca.

Readers are cautioned that the foregoing list of factors is not exhaustive of the factors that may affect forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. For more information on the Company, investors are encouraged to review the Company’s public filings on SEDAR+ at www.sedarplus.ca .

Proposed combination seeks to establish a Nasdaq-listed longevity and precision-health platform, complementing Veea’s continuing edge AI infrastructure business; GeoNova Capital commits US$10 million as cornerstone institutional investor

NEW YORK and AMSTERDAM, Sept. 14, 2026 (GLOBE NEWSWIRE) — Veea Inc. (NASDAQ: VEEA), a provider of AI-powered, cybersecure edge infrastructure, and NovaGen Group B.V., a personalized regenerative medicine and longevity company, today announced they have signed a term sheet to combine and are targeting execution of a definitive business combination agreement within the coming weeks. In connection with the business combination, the parties have also announced an agreement to launch NovaGen Health Networks: a connected health platform integrating Veea’s edge computing, connectivity and cybersecurity capabilities with NovaGen’s cellular reprogramming science and clinical services. Initial deployments will begin at NovaGen clinics and partner hospitals in Q4 2026.

The platform, built on VeeaONE, connects health records, wearable and sensor data, and biological measurements into a patient-controlled longitudinal health profile. Local computing supports agentic AI applications close to the patient, with patient-directed permissions governing access to personal data. Rollout begins with connected health services and will expand to clinician-supervised diagnostics and therapy pathways as clinical validation and applicable regulatory authorizations permit.

GeoNova Capital, as cornerstone investor, has signed a term sheet to provide an initial US$10 million investment in the combined company. Veea will continue to grow and serve its existing customers, partners and markets. Management believes that, based on its internal projections and an independent valuation prepared using such internal projections, the value of the combined company is approximately $750 million.

The business combination between Veea and NovaGen, as well as the investment by GeoNova Capital, remains subject to the negotiation and execution of definitive documentation and the satisfaction of certain conditions to closing by the parties.

The companies plan to roll out NovaGen Health Networks in two phases.

Phase 1 – Connecting People, Data and Care (Q4 2026)
NovaGen Health Networks will provide a private household health hub with a digital twin for every family member and a patient-controlled health records wallet, integrating health records, wearable telemetry and longitudinal biological measurements. Built on VeeaONE, the hub processes sensitive data locally and supports AI wellness companions, medication reminders, and patient-authorized provider sharing. Plans include personal cell banking and consented research participation, subject to applicable regulatory requirements.

Phase 2 – Clinician-Supervised Diagnostics and Therapy Pathways
As clinical validation and regulatory authorizations permit, the network will combine digital twins and medical records with cellular data from the small skin biopsy used to initiate the ARC Prometheus process. This biopsy provides a patient’s own fibroblasts for cellular reprogramming, rejuvenation, cell banking and potential future autologous therapies. Telomere length, DNA-methylation age and additional biomarkers will be assessed to support clinician evaluation of therapy candidates and treatment monitoring. Validated AI tools will support clinician-reviewed decisions and referrals to authorized treatment centers.

“NovaGen is a regenerative medicine platform with proprietary autologous rejuvenated fibroblast stem cell technology and a growing network of associated clinics. This agreement with Veea extends our reach to individuals long before they walk into a clinic,” said Diederik van der Reijt, CEO of NovaGen Group. “NovaGen Health Networks creates a pathway to identify and evaluate potential candidates for our therapies, allowing that relationship to begin earlier and continue through assessment, treatment and follow-up, including the creation of each patient’s own digital twin.”

“NovaGen Health Networks demonstrates the power of AI at the edge, bringing Veea’s connectivity, computing, cybersecurity, storage and AI capabilities together in one global network, putting intelligence where care happens while giving people far greater control over their most personal information,” said Allen Salmasi, Chairman and CEO of Veea.

Data Sovereignty and Privacy
Patient privacy and data sovereignty are central to the network’s design. Health records remain encrypted at source and off the blockchain; the blockchain ledger records only permissions, document fingerprints and access events. Patients authorize specific recipients, categories of information and access periods, and may revoke access at any time. Cloud services use pseudonymous digital twins, with re-identification controlled through protected keys and authorized consent. Veea’s cybersecurity architecture, incorporating Zero Trust Network Access, network slicing, micro-segmentation and AI-driven anomaly detection, protects the network end-to-end.

“GeoNova’s US$10 million commitment reflects our conviction in NovaGen’s strategy and the scale of the opportunity. As corporate adviser and cornerstone institutional investor, our role is to support NovaGen with institutional capital, capital-markets discipline and strategic execution as it advances toward the U.S. public markets,” said Robert Hamilton, Managing Partner, Capital Markets, GeoNova Capital.

About Veea
Veea Inc. (NASDAQ: VEEA) is a global leader in edge solutions and infrastructure. Founded in 2014 and headquartered in New York City, Veea enables enterprises, service providers and public sector organizations to deploy AI-powered applications at the edge. The VeeaONE platform integrates connectivity, computing, cybersecurity and storage into a unified hyperconverged network solution, from edge to cloud. Veea holds more than 123 patents across related technology domains and has been recognized by Gartner for its innovations in edge computing. www.veea.com

About NovaGen Group
NovaGen Group has developed a personalized regenerative medicine and longevity platform integrating ARC Prometheus cellular reprogramming and rejuvenation technology, biological assessment, cell banking, clinical services and digital health. Its strategy connects research and clinical development with a growing network of care locations and partners to support more personalized approaches to health and aging. www.novagengroup.com

About GeoNova Capital
GeoNova Capital is a UAE-based investment and capital-markets firm focused on event-driven investing, structured finance, special situations and public-market transactions. GeoNova is supporting NovaGen as corporate adviser and cornerstone institutional investor.

Media Contacts
Thomas Latiolais — thomas.latiolais@veea.com
Karen Brink — karen@novagengroup.com

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements typically include projections of future revenues, earnings, strategies, and operational growth. These statements are based on current beliefs, assumptions and expectations and involve known and unknown risks and uncertainties that could cause actual results to differ materially from current projections due to factors including, but not limited to, market conditions, economic shifts, and operational challenges. Operational factors that could cause results to differ include Veea’s ability to maintain adequate financial resources, execute its growth strategy, achieve market acceptance, and compete effectively. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “will” and similar expressions. Forward-looking statements speak only as of the date made. Veea disclaims any obligation to update them publicly.

TORONTO, Sept. 14, 2026 (GLOBE NEWSWIRE) — Topicus.com Inc. (“Topicus”) announced today Robin van Poelje’s decision to retire from his position as Chief Executive Officer of Topicus for personal reasons. Ramon Zanders, currently the Group CEO of the Total Specific Solutions Blue operating group within Topicus, has been appointed Chief Executive Officer of Topicus by the Topicus Board of Directors. These changes will be effective October 1, 2026. Following his retirement as Chief Executive Officer, Mr. van Poelje will continue as a Director and Chairman of the Board of Topicus.

Mark Milller, President of Constellation Software, and a Director of Topicus.com Cooperatief U.A., said, “Robin has led Topicus, and its predecessor TSS, with tremendous discipline and integrity for over sixteen years. Speaking on behalf of the board and all of the employees of Topicus, we are immensely grateful for the leadership he’s provided to this company. We wish him well. We’re fully confident in Ramon and the rest of the executive team at Topicus to deliver a seamless transition.”

Mr. Zanders will continue his role as Group CEO of TSS Blue alongside his new responsibilities. His continued leadership ensures no change to TSS Blue’s day-to-day leadership. Mr. Zanders has also been appointed as a director of Topicus.

As part of these leadership changes, the Topicus Board plans to implement an enhanced decentralization strategy for its TSS operating groups. Each such operating group will be expected to operate as an autonomous, stand-alone entity, while respecting the rights of the parties to Topicus’ Investor Rights and Governance Agreement.

The Total Specific Solutions Public operating group, led by Han Knooren, expects to change its name in the near future, as it transitions into an autonomous, stand-alone operating group, which name change will be publicly announced once complete.

In addition, Daan Dijkhuizen, the Group CEO of the Topicus operating group, has agreed to join and support Constellation’s drive to further accelerate AI-first initiatives across the Constellation group of companies. Mark Miller commented, “We’re very fortunate to benefit from Daan’s extensive experience and expertise in supporting our AI implementation strategy.”

About Topicus.com 
Topicus’ subordinate voting shares are listed on the TSX Venture Exchange under the symbol “TOI”. Topicus.com is a leading pan-European provider of vertical market software and vertical market platforms to clients in public and private sector markets. Operating and investing in countries and markets across Europe with long-term growth potential, Topicus acquires, builds and manages leading software companies providing specialized, mission-critical and high-impact software solutions that address the particular needs of customers.

For further information, contact:

Topicus.com Inc.
Jamal Baksh, Chief Financial Officer
Tel: (416) 861-9677
jbaksh@csisoftware.com
www.topicus.com

Forward Looking Statements

Certain statements herein may be “forward looking” statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Topicus or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.   Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Topicus assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

BETHESDA, Md., Sept. 14, 2026 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, will report third quarter 2026 financial results on Wednesday, November 4, 2026, after the market close.

The Company will hold a conference call to discuss its third quarter 2026 results and business outlook on Thursday, November 5, 2026, at 10:00 a.m. ET. Conference call access information is as follows:

Conference Call:

USA/Canada Toll Free Number 833-461-5787
Conference ID 283070262
 

A simultaneous webcast of the call will be available on the Company’s website at www.hosthotels.com.

A replay of the call will be available Thursday, November 5, 2026, until Wednesday, February 10, 2027, via webcast on the Company’s website.

ABOUT HOST HOTELS & RESORTS

Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 70 properties in the United States and five properties internationally totaling approximately 41,300 rooms. The Company also holds non-controlling interests in seven domestic joint ventures.

SOURAV GHOSH
Chief Financial Officer
(240) 744-5267

JAIME MARCUS
Investor Relations
(240) 744-5117
ir@hosthotels.com

ATLANTA, Sept. 14, 2026 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that Brooke Pierce has been appointed President, Health, effective September 14, 2026.

In this role, Ms. Pierce will lead the Company’s Health business group, encompassing work in technology, scientific research, data analytics, artificial intelligence, and mission-support services across federal health markets. She will be responsible for advancing the strategic direction and growth of DLH’s health portfolio, while ensuring operational execution, deepening customer engagement, and fostering employee development.

Ms. Pierce brings nearly 20 years of experience leading large-scale federal programs, including health missions spanning the National Institutes of Health (“NIH”), the Centers for Medicare & Medicaid Services (“CMS”), the Food and Drug Administration (“FDA”), the Substance Abuse & Mental Health Services Administration (“SAMHSA”), the Centers for Disease Control and Prevention (“CDC”), as well as the commercial healthcare market. In her role supporting CMS, she was recognized with a FedHealthIT100 Award for advancing innovation and transformation in federal Health IT.

Ms. Pierce most recently provided executive leadership for an enterprise IT program generating more than $600 million in annual revenue. In that role, she directed a team of approximately 2,000 employees delivering cybersecurity, cloud services, and AI-enabled modernization across hundreds of global sites supporting millions of users. Previous roles include leading a large federal health organization with responsibility for a $350 million portfolio and approximately 600 employees in support of CMS and a team delivering clinical, financial, and operational systems in the commercial healthcare market.

“Brooke’s experience building high-performing health and technology organizations that deliver operational excellence to customers, profitable growth, and organizational development at scale will be invaluable as we advance DLH’s health strategy,” said DLH President & CEO Kathryn JohnBull. “Her record leading complex federal health and technology organizations will strengthen execution across our portfolio. We are thrilled to welcome Brooke to DLH and look forward to the leadership and perspective she will bring to our customers, our employees, and our organization.”

About DLH

DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

Contact Information:

Investor Relations

investorrelations@dlhcorp.com

Media

communications@dlhcorp.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding the anticipated use of proceeds. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Opened 19 new stores during the quarter 
Significant decrease in inventory balance compared to the prior year

SECAUCUS, N.J., Sept. 14, 2026 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), one of the only pure-play children’s specialty retailers in North America with an omni-channel presence, today announced financial results for the Company’s second fiscal quarter ended August 1, 2026.

Muhammad Asif Seemab, President and Interim Chief Executive Officer said, “During the quarter, we continued to contend with stabilizing our customer file, driving traffic to our stores and websites, and lower conversion, combined with a very clearance-heavy mix. The transition of our e-commerce operations to Salesforce has also taken longer than anticipated, which has contributed in part to the sales decline. Further, last year’s strong back-to-school demand was uniquely elevated by customer demand ahead of anticipated tariff price increases, which skewed those financial results compared to this year’s. Despite the near-term headwinds, we continue to invest in the long-term strength of the business focused on our strategic priorities: improving our customer experience, strengthening and elevating the brand, delivering on financial targets and enhancing organization leadership.”

Mr. Seemab continued, “During the quarter, we opened 19 new stores, which is the most in any quarter since 2013, and we remained focused on boosting the profitability of our fleet. We implemented new turnaround capabilities into the market for the first time during this back-to-school season, focused on enhancing our understanding of the effectiveness of our brand media. We have integrated AI to enhance the user-friendliness of our website and coordinated national brand events that generated more customer engagement. Early results from these new initiatives are encouraging: brand media generated a measured return of over 7-times, while AI-enabled creative optimization is already increasing e-commerce conversion and will be scaled further for the upcoming holiday season. Our traffic trends have improved in August relative to July, and we plan to build on these capabilities and continue the momentum into the holiday season. We are also advancing our international growth strategy by hiring Alexandra Derner as Chief Growth Officer, with a mandate to increase the global reach of the brand, including our planned entry into Mexico.”

Mr. Seemab concluded, “When I took on this role two months ago, I had a clear mandate to strengthen the Company’s financial position and liquidity. While we continue to execute our transformation plan and remain focused on cost reduction in all aspects of the business to optimize efficiencies, we are also evaluating our operating model to function in a profitable manner and improve our immediate liquidity position. I am excited about the opportunities ahead as we continue to execute on our long-term transformation plans.”

Second Quarter 2026 Results
Net sales decreased $56.2 million, or 18.9%, to $241.8 million in the three months ended August 1, 2026, compared to $298.0 million in the three months ended August 2, 2025. The decrease in net sales was driven by a decrease in direct-to-consumer (“DTC”) sales of 15.0% due to lower traffic compared to the prior year. Comparable retail sales in our owned and operated DTC business decreased 16.7% for the quarter. Our consolidated results were also impacted by the planned reduction in shipments for our wholesale channel to align inventory positions with our customers, and to liquidate aged fashion inventories. These negative trends have started to reverse during the beginning of the third quarter as our wholesale partners build back their inventory levels ahead of the holiday season.

Gross profit decreased $18.0 million to $83.3 million in the three months ended August 1, 2026, compared to $101.3 million in the three months ended August 2, 2025. Gross margin increased 40 basis points (“bps”) to 34.4% during the three months ended August 1, 2026, compared to 34.0% in the prior year. The increase in gross margin was caused primarily by the impact of tariff refunds recognized during the quarter amounting to $39 million, which was accounted for as a reduction of Cost of sales. Excluding the impact of these refunds, our gross margin decreased 1,550 bps primarily due to a higher penetration of markdown sales (590 bps), higher tariffs on our product (330 bps), increased store occupancy costs due to new store openings (260 bps), and an increase in inventory reserves (250 bps), partially offset by favorable product mix and costs (100 bps). Adjusted gross profit decreased $17.6 million to $83.7 million in the three months ended August 1, 2026, compared to $101.3 million in the three months ended August 2, 2025. Adjusted gross margin increased 60 bps to 34.6% during the three months ended August 1, 2026, compared to 34.0% in the prior year, inclusive of the impact of tariff refunds.

Selling, general, and administrative expenses increased $0.5 million to $90.1 million in the three months ended August 1, 2026, compared to $89.6 million in the three months ended August 2, 2025, and deleveraged 710 bps to 37.2% of net sales. The increase was primarily due to an increase in store expenses as we opened 19 new stores, combined with the impact of unfavorable foreign currency exchange movements, partially offset by lower marketing expense as we continue to focus on rationalizing our spend, and lower payroll costs from our transformation efforts. Adjusted selling, general, and administrative expenses were $88.3 million in the three months ended August 1, 2026, compared to $87.6 million in the prior year, and deleveraged 710 bps to 36.5% of net sales.

Operating income (loss) was a loss of $(13.0) million in the three months ended August 1, 2026, compared to income of $4.1 million in the three months ended August 2, 2025 and deleveraged 680 bps to (5.4)% of net sales. Adjusted operating loss was $(10.9) million in the three months ended August 1, 2026, compared to Adjusted operating income of $6.1 million in the prior year, and deleveraged 650 bps to (4.5)% of net sales.

Net interest expense was $18.3 million in the three months ended August 1, 2026, compared to $8.0 million in the three months ended August 2, 2025. The increase was due to the amortization of financing costs associated with the monetization of our tariff refund claims and income tax receivable claim. Excluding the impact of these costs, net interest expense decreased $0.4 million due to lower average borrowings and interest rates on our debt facilities.

Provision (benefit) for income taxes was a benefit of $0.3 million in the three months ended August 1, 2026, compared to a provision of $1.5 million in the three months ended August 2, 2025. The change was primarily due to a higher pretax loss and changes in forecasted earnings mix.

Net loss was $(31.0) million, or $(1.39) per diluted share, in the three months ended August 1, 2026, compared to $(5.4) million, or $(0.24) per diluted share, in the three months ended August 2, 2025. Adjusted net loss was $(18.2) million, or $(0.82) per diluted share, compared to $(3.4) million, or $(0.15) per diluted share, in the prior year.

Fiscal Year-To-Date 2026 Results
Net sales decreased $83.1 million, or 15.4%, to $457.0 million in the six months ended August 1, 2026, compared to $540.1 million in the six months ended August 2, 2025. The decrease in net sales was driven by a decrease in DTC sales due to lower traffic. Comparable retail sales in our owned and operated DTC business decreased 12.9% for the six months ended August 1, 2026. Our consolidated results were also impacted by the planned reduction in shipments for our wholesale channel to align inventory positions with our customers, and to liquidate aged fashion inventories. These negative trends have started to reverse during the beginning of the third quarter as our wholesale partners build back their inventory levels ahead of the holiday season.

Gross profit decreased $35.4 million to $136.6 million in the six months ended August 1, 2026, compared to $172.1 million in the six months ended August 2, 2025. Gross margin decreased 200 bps to 29.9% during the six months ended August 1, 2026, compared to 31.9% in the prior year. Excluding the impact of tariff refunds recognized during the year amounting to $39 million, which was accounted for as a reduction of Cost of sales, our gross margin decreased 1,040 bps primarily due to a higher penetration of markdown sales (420 bps), higher tariffs on our product (350 bps), increased store occupancy costs due to new store openings (190 bps), and an increase in inventory reserves (170 bps), partially offset by favorable product mix and costs (190 bps). Adjusted gross profit decreased $30.8 million to $141.3 million in the six months ended August 1, 2026, compared to $172.1 million in the six months ended August 2, 2025. Adjusted gross margin decreased 100 bps to 30.9% during the six months ended August 1, 2026, compared to 31.9% in the prior year, inclusive of the impact of tariff refunds.

Selling, general, and administrative expenses increased $2.7 million to $178.9 million in the six months ended August 1, 2026, compared to $176.3 million in the six months ended August 2, 2025 and deleveraged 650 bps to 39.1% of net sales. The increase was primarily due to an increase in store expenses as we opened 20 new stores, combined with the impact of unfavorable foreign currency exchange movements, partially offset by a reduction in marketing expense as we continue to focus on rationalizing our spend, and a decrease in long-term incentive compensation. Adjusted selling, general, and administrative expenses were $175.8 million in the six months ended August 1, 2026, compared to $174.2 million in the prior year, and deleveraged 630 bps to 38.5% of net sales.

Operating loss was $(55.2) million in the six months ended August 1, 2026, compared to $(20.0) million in the six months ended August 2, 2025. Adjusted operating loss was $(47.1) million in the six months ended August 1, 2026, compared to $(17.9) million in the prior year.

Net interest expense was $27.9 million in the six months ended August 1, 2026, compared to $16.6 million in the six months ended August 2, 2025. The increase was due to the amortization of financing costs associated with the monetization of our tariff refund claims and income tax receivable claim. Excluding the impact of these costs, net interest expense decreased $1.0 million due to lower average borrowings and interest rates on our debt facilities.

Provision for income taxes was $1.0 million in the six months ended August 1, 2026, compared to $2.8 million during the six months ended August 2, 2025. The change was primarily due to a higher pretax loss and changes in forecasted earnings mix.

Net loss was $(84.1) million, or $(3.79) per diluted share, in the six months ended August 1, 2026, compared to $(39.4) million, or $(1.80) per diluted share, in the six months ended August 2, 2025. Adjusted net loss was $(62.6) million, or $(2.82) per diluted share, compared to $(36.3) million, or $(1.66) per diluted share, in the prior year.

Store Update
The Company opened 19 and closed 2 stores in the three months ended August 1, 2026, and ended the quarter with 514 stores, compared to 494 stores as of August 2, 2025.

Balance Sheet and Cash Flow
As of August 1, 2026, the Company had $7.2 million in cash and cash equivalents, $47.5 million in borrowing availability under its revolving credit facility, and an additional $25.0 million of availability under the unsecured Commitment Letter provided by Mithaq, representing total liquidity of $79.7 million. The Company had $160.1 million outstanding on its revolving credit facility. Additionally, the Company used $(32.3) million in operating cash flows (inclusive of tariff refunds) in the six months ended August 1, 2026, compared to $(73.4) million in the six months ended August 2, 2025.

Inventories were $340.2 million as of August 1, 2026, compared to $442.7 million as of August 2, 2025, reflecting a decrease of $102.5 million, or 23.2%. These reduced inventory levels were a result of improved inventory management as the Company continues to align its inventory levels with anticipated demand and sell through excess inventory on hand.

Non-GAAP Reconciliation
The Company’s results are reported in this press release on a GAAP and as adjusted, non-GAAP basis. Adjusted net income (loss), adjusted net income (loss) per diluted share, adjusted gross profit, adjusted selling, general, and administrative expenses, and adjusted operating income (loss) are non-GAAP measures, and are not intended to replace GAAP financial information, and may be different from non-GAAP measures reported by other companies. The Company believes the income and expense items excluded as non-GAAP adjustments are not reflective of the performance of its core business, and that providing this supplemental disclosure to investors will facilitate comparisons of the past and present performance of its core business.

Please refer to the “Reconciliation of Non-GAAP Financial Information to GAAP” later in this press release, which sets forth the non-GAAP operating adjustments for the 13-week and 26-week periods ended August 1, 2026 and August 2, 2025.

About The Children’s Place
The Children’s Place is one of the only pure-play children’s specialty retailers in North America with an omni-channel presence. Its global retail and wholesale network includes two digital storefronts, 514 stores in North America, wholesale marketplaces and distribution in 13 countries through ten international franchise and wholesale partners. The Children’s Place designs, contracts to manufacture, and sells fashionable, high-quality, head-to-toe outfits predominantly at value prices, primarily under its proprietary brands: “The Children’s Place” and “Gymboree”. For more information, visit: www.childrensplace.com and www.gymboree.com.  

Forward-Looking Statements
This press release contains or may contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements relating to the Company’s strategic initiatives and results of operations, including adjusted net income (loss) per diluted share. Forward-looking statements typically are identified by use of terms such as “may,” “will,” “should,” “plan,” “project,” “expect,” “anticipate,” “estimate,” “believe” and similar words, although some forward-looking statements are expressed differently.

These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results and performance to differ materially.

Some of these risks and uncertainties are described in the Company’s filings with the Securities and Exchange Commission, including in the “Part I, Item1A. Risk Factors” section of its annual report on Form 10-K for the fiscal year ended January 31, 2026.

Included among the risks and uncertainties that could cause actual results and performance to differ materially are the risk that the Company will be unable to achieve operating results at levels sufficient to fund and/or finance the Company’s current level of operations and repayment of indebtedness, the risk that changes in trade policy and tariff regimes, including newly imposed U.S. tariffs and any responsive non-U.S. tariffs, may impact the Company’s international manufacturing and operations or customers’ discretionary spending habits, the risk that the Company will be unsuccessful in gauging fashion trends and changing consumer preferences, the risks resulting from the highly competitive nature of the Company’s business and its dependence on consumer spending patterns, which may be affected by changes in economic conditions (including inflation), the risk that changes in the Company’s plans and strategies with respect to pricing, capital allocation, capital structure, investor communications and/or operations may have a negative effect on the Company’s business, the risk that the Company’s strategic initiatives to increase sales and margin, improve operational efficiencies, enhance operating controls, decentralize operational authority and reshape the Company’s culture are delayed or do not result in anticipated improvements, the risk of delays, interruptions, disruptions and higher costs in the Company’s global supply chain, including resulting from disease outbreaks, foreign sources of supply in less developed countries, more politically unstable countries, or countries where vendors fail to comply with industry standards or ethical business practices, including the use of forced, indentured or child labor, the risk that the cost of raw materials or energy prices will increase beyond current expectations or that the Company is unable to offset cost increases through value engineering or price increases, various types of litigation, including class action litigation brought under securities, consumer protection, employment, and privacy and information security laws and regulations, risks related to the existence of a controlling stockholder, and the uncertainty of weather patterns, as well as other risks discussed in the Company’s filings with the SEC from time to time.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact:  Investor Relations (201) 558-2400 ext. 14500

       
THE CHILDREN’S PLACE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
       
  Second Quarter Ended   Year-to-Date Ended
  August 1, 2026   August 2, 2025   August 1, 2026   August 2, 2025
               
Net sales $ 241,800     $ 298,006     $ 457,025     $ 540,131  
Cost of sales (exclusive of depreciation and amortization)   158,522       196,734       320,397       368,076  
Gross profit   83,278       101,272       136,628       172,055  
Selling, general and administrative expenses   90,061       89,596       178,925       176,266  
Depreciation and amortization   6,254       7,570       12,920       15,800  
Operating income (loss)   (13,037 )     4,106       (55,217 )     (20,011 )
Related party interest expense   (2,099 )     (1,868 )     (4,041 )     (3,740 )
Other interest expense, net   (16,153 )     (6,150 )     (23,900 )     (12,840 )
Loss before provision (benefit) for income taxes   (31,289 )     (3,912 )     (83,158 )     (36,591 )
Provision (benefit) for income taxes   (338 )     1,453       984       2,797  
Net loss $ (30,951 )   $ (5,365 )   $ (84,142 )   $ (39,388 )
               
               
Loss per common share              
Basic $ (1.39 )   $ (0.24 )   $ (3.79 )   $ (1.80 )
Diluted $ (1.39 )   $ (0.24 )   $ (3.79 )   $ (1.80 )
               
Weighted average common shares outstanding              
Basic   22,237       22,142       22,223       21,885  
Diluted   22,237       22,142       22,223       21,885  
                               

THE CHILDREN’S PLACE, INC.
RECONCILIATION OF NON-GAAP FINANCIAL INFORMATION TO GAAP
(In thousands, except per share amounts)
(Unaudited)
       
  Second Quarter Ended   Year-to-Date Ended
  August 1, 2026   August 2, 2025   August 1, 2026   August 2, 2025
               
Net loss $ (30,951 )   $ (5,365 )   $ (84,142 )   $ (39,388 )
               
Non-GAAP adjustments:              
Exit from third-party distribution facility   390       —       5,010       —  
Financing charges on monetization of tariff refund claims   9,865       —       11,929       —  
Restructuring costs   1,713       1,211       3,151       2,145  
Financing charges on monetization of income tax receivable   762       —       1,490       —  
Loss on extinguishment of debt   —       —       —       1,039  
Legal settlement accrual / reversal   —       750       —       (46 )
Aggregate impact of non-GAAP adjustments   12,730       1,961       21,580       3,138  
Income tax effect(1)   —       —       —       —  
Net impact of non-GAAP adjustments   12,730       1,961       21,580       3,138  
               
Adjusted net loss $ (18,221 )   $ (3,404 )   $ (62,562 )   $ (36,250 )
               
GAAP net loss per common share $ (1.39 )   $ (0.24 )   $ (3.79 )   $ (1.80 )
               
Adjusted net loss per common share $ (0.82 )   $ (0.15 )   $ (2.82 )   $ (1.66 )
               
% of Net Sales (GAAP)   (12.8 )%     (1.8 )%     (18.4 )%     (7.3 )%
% of Net Sales (As adjusted)   (7.5 )%     (1.1 )%     (13.7 )%     (6.7 )%
               

(1) The tax effects of the non-GAAP items are calculated based on the statutory rate of the jurisdiction in which the discrete item resides, adjusted for the impact of any valuation allowance.

 
THE CHILDREN’S PLACE, INC.
RECONCILIATION OF NON-GAAP FINANCIAL INFORMATION TO GAAP
(In thousands)
(Unaudited)
       
  Second Quarter Ended   Year-to-Date Ended
  August 1, 2026   August 2, 2025   August 1, 2026   August 2, 2025
               
Operating income (loss) $ (13,037 )   $ 4,106     $ (55,217 )   $ (20,011 )
               
Non-GAAP adjustments:              
Exit from third-party distribution facility   390       —       5,010       —  
Restructuring costs   1,713       1,211       3,151       2,145  
Reversal of legal settlement accrual   —       750       —       (46 )
Aggregate impact of non-GAAP adjustments   2,103       1,961       8,161       2,099  
               
Adjusted operating income (loss) $ (10,934 )   $ 6,067     $ (47,056 )   $ (17,912 )
               
% of Net Sales (GAAP)   (5.4 )%     1.4 %     (12.1 )%     (3.7 )%
% of Net Sales (As adjusted)   (4.5 )%     2.0 %     (10.3 )%     (3.3 )%
                   

THE CHILDREN’S PLACE, INC.
RECONCILIATION OF NON-GAAP FINANCIAL INFORMATION TO GAAP
(In thousands)
(Unaudited)
       
  Second Quarter Ended   Year-to-Date Ended
  August 1, 2026   August 2, 2025   August 1, 2026   August 2, 2025
               
Gross profit $ 83,278     $ 101,272     $ 136,628     $ 172,055  
               
Non-GAAP adjustments:              
Exit from third-party distribution facility   390       —       4,681       —  
Aggregate impact of non-GAAP adjustments   390       —       4,681       —  
               
Adjusted gross profit $ 83,668     $ 101,272     $ 141,309     $ 172,055  
               
% of Net Sales (GAAP)   34.4 %     34.0 %     29.9 %     31.9 %
% of Net Sales (As adjusted)   34.6 %     34.0 %     30.9 %     31.9 %
                               

  Second Quarter Ended   Year-to-Date Ended
  August 1, 2026   August 2, 2025   August 1, 2026   August 2, 2025
               
Selling, general and administrative expenses $ 90,061     $ 89,596     $ 178,925     $ 176,266  
               
Non-GAAP adjustments:              
Restructuring costs   1,713       1,211       3,151       2,145  
Legal settlement accrual   —       750       —       (46 )
Aggregate impact of non-GAAP adjustments   1,713       1,961       3,151       2,099  
               
Adjusted selling, general and administrative expenses $ 88,348     $ 87,635     $ 175,774     $ 174,167  
               
% of Net Sales (GAAP)   37.2 %     30.1 %     39.1 %     32.6 %
% of Net Sales (As adjusted)   36.5 %     29.4 %     38.5 %     32.2 %
                               

THE CHILDREN’S PLACE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
           
  August 1,
2026

  January 31,
2026*
  August 2,
2025

Assets:          
Cash and cash equivalents $ 7,176     $ 5,489     $ 7,798  
Accounts receivable   44,616       25,967       54,365  
Inventories   340,213       325,100       442,705  
Prepaid expenses and other current assets   34,090       41,441       38,987  
Total current assets   426,095       397,997       543,855  
           
Property and equipment, net   84,924       81,658       89,445  
Right-of-use assets   207,793       164,495       151,145  
Tradenames, net   13,000       13,000       13,000  
Other assets   10,495       13,149       7,652  
Total assets $ 742,307     $ 670,299     $ 805,097  
           
Liabilities and Stockholders’ Deficit:          
Revolving loan $ 160,080     $ 131,078     $ 294,417  
Accounts payable   146,201       108,481       132,436  
Current portion of operating lease liabilities   62,772       57,236       60,546  
Income tax payable   1,646       2,945       2,043  
Short-term debt   17,833       —       —  
Accrued expenses and other current liabilities   91,261       88,149       94,454  
Total current liabilities   479,793       387,889       583,896  
           
Long-term debt   97,718       97,588       —  
Related party long-term debt   122,895       107,554       107,193  
Long-term portion of operating lease liabilities   161,249       120,410       103,982  
Other tax liabilities   3,626       3,520       5,523  
Other long-term liabilities   15,998       7,521       9,370  
Total liabilities   881,279       724,482       809,964  
           
Stockholders’ deficit   (138,972 )     (54,183 )     (4,867 )
Total liabilities and stockholders’ deficit $ 742,307     $ 670,299     $ 805,097  
                       

* Derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2026.

   
THE CHILDREN’S PLACE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
   
  Year-to-Date Ended
  August 1, 2026   August 2, 2025
       
Net loss $ (84,142 )   $ (39,388 )
Non-cash adjustments   60,310       57,734  
Working capital   (8,467 )     (91,782 )
Net cash used in operating activities   (32,299 )     (73,436 )
       
Net cash used in investing activities   (13,698 )     (4,843 )
       
Net cash provided by financing activities   48,382       77,754  
       
Effect of exchange rate changes on cash and cash equivalents   (698 )     2,976  
       
Net increase in cash and cash equivalents   1,687       2,451  
       
Cash and cash equivalents, beginning of period   5,489       5,347  
       
Cash and cash equivalents, end of period $ 7,176     $ 7,798  
               

HOUSTON, Sept. 14, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) (“Sysco” or the “Company”) today announced that it intends to make an offering of $1.0 billion of shares of its common stock (the “Offering”). Sysco’s common stock is listed on the New York Stock Exchange under the symbol “SYY.”

Sysco intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional $150 million of shares of common stock, solely to cover overallotments, if any, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering.

Sysco intends to use the net proceeds from the Offering to finance a portion of the consideration for its pending acquisition of Jetro Restaurant Depot. The Offering is not contingent on the consummation of the acquisition.

Goldman Sachs & Co. LLC and TD Securities (USA) LLC are acting as lead book-running managers for the Offering. BofA Securities, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are also acting as book-running managers for the Offering.

The Offering will be made by means of a prospectus supplement under Sysco’s shelf registration statement on Form S-3ASR, as filed with the Securities and Exchange Commission (the “SEC”).

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale is unlawful. The Offering is being made only by means of a prospectus supplement relating to the Offering and the accompanying prospectus.

Copies of the preliminary prospectus supplement for the Offering and the accompanying prospectus may be obtained free of charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies may be obtained from:

  • Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526, or by e-mail at prospectus-ny@ny.email.gs.com;
  • TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at TDManualrequest@broadridge.com;
  • BofA Securities, Attention: Prospectus Department, 201 North Tryon Street, Charlotte, NC 28255-0001, or by e-mail at dg.prospectus_requests@bofa.com;
  • J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by e-mail at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com; or
  • Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, by telephone at 800-645-3751 (option #5) or by email at WFScustomerservice@wellsfargo.com.

About Sysco

Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 333 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 670,000 customer locations. The company generated sales of more than $84 billion in fiscal year 2026 that ended June 27, 2026.

As the world’s largest food-away-from-home distributor, Sysco offers customized supply chain solutions, bespoke specialty product offerings, and culinary support to drive customers to innovate and optimize their operations. We act as a trusted business partner to our customers, helping them grow through our industry-leading portfolio that includes fresh produce, premium proteins, specialty products, sustainably focused items, equipment and supplies, and innovative culinary solutions.

SYY-INVESTORS

Forward-Looking Statements

Statements made in this press release include statements that are forward-looking or that express management’s beliefs, expectations or hopes and are forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding the terms, timing and completion of the Offering and our anticipated use of the proceeds thereof, statements about our future financial performance and results, business strategy, plans, goals and objectives, and other statements that are not historical facts, including expectations regarding our future growth, including growth in sales and earnings per share, expectations regarding cost savings associated with AI, as well as statements about the expected timing and completion of the proposed transaction with Jetro Restaurant Depot and the anticipated benefits of such proposed transaction.

Such forward-looking statements reflect the views of management at the time such statements are made and are subject to a number of risks, uncertainties, estimates, and assumptions, including those outside of Sysco’s control. Risks and uncertainties include without limitation: the impact of geopolitical, economic and market conditions and developments, including changes in global trade policies and tariffs and foreign conflicts; risks related to our business initiatives; periods of significant or prolonged inflation or deflation and their impact on our product costs, volume, foot traffic, and profitability generally; risks related to our efforts to implement our transformation initiatives and meet our other long-term strategic objectives; risks of interruption of supplies and increase in product costs; risks related to changes in consumer eating habits; and impact of natural disasters or adverse weather conditions, public health crises, adverse publicity or lack of confidence in our products, and product liability claims as well as risks and uncertainties associated with our proposed transaction with Jetro Restaurant Depot, including but not limited to, the occurrence of any event, change or other circumstances that could give rise to the right of either or both parties to terminate the merger agreement; the risk that regulatory approvals may not be obtained or other closing conditions may not be satisfied in a timely manner or at all, as well as the risk that regulatory approvals are obtained subject to conditions that are not anticipated; the risk of other delays in closing the transaction; the possibility that any of the anticipated benefits and projected synergies of the transaction will not be realized or will not be realized within the expected time period; and the risk that the proposed transaction and its announcement could have an adverse effect on the market price of the common stock of Sysco. Should one or more of these risks or uncertainties materialize, or underlying assumptions prove incorrect, actual results may vary materially from those indicated in our forward-looking statements. Therefore, you should not place undue reliance on any of the forward-looking statements contained herein. For more information on these risks and other concerning factors that could cause actual results to differ from those expressed or forecasted, see our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the SEC. We do not undertake to update our forward-looking statements, except as required by applicable law.

For more information contact:
 
Kevin Kim Cassandra Mauel 
Investor Contact Media Contact 
kevin.kim@sysco.com cassandra.mauel@sysco.com 
T 281-584-1219 T 281-584-1390

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.